東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/13 | 1,842 | 1,901 | 1,777 | 1,855 | -67 | -3.5% | 245,200 |
2020/03/12 | 1,980 | 1,989 | 1,903 | 1,922 | -86 | -4.3% | 241,600 |
2020/03/11 | 2,046 | 2,076 | 2,005 | 2,008 | -45 | -2.2% | 207,400 |
2020/03/10 | 2,059 | 2,082 | 1,931 | 2,053 | +44 | +2.2% | 240,300 |
2020/03/09 | 2,072 | 2,088 | 2,001 | 2,009 | -110 | -5.2% | 222,600 |
2020/03/06 | 2,163 | 2,163 | 2,095 | 2,119 | -25 | -1.2% | 164,500 |
2020/03/05 | 2,187 | 2,193 | 2,113 | 2,144 | +7 | +0.3% | 186,900 |
2020/03/04 | 2,096 | 2,156 | 2,090 | 2,137 | -4 | -0.2% | 141,100 |
2020/03/03 | 2,237 | 2,250 | 2,140 | 2,141 | -1 | ±0% | 305,300 |
2020/03/02 | 2,094 | 2,169 | 2,084 | 2,142 | -2 | -0.1% | 207,300 |
2020/02/28 | 2,135 | 2,175 | 2,128 | 2,144 | -41 | -1.9% | 199,700 |
2020/02/27 | 2,220 | 2,239 | 2,180 | 2,185 | -68 | -3% | 253,100 |
2020/02/26 | 2,255 | 2,267 | 2,226 | 2,253 | -52 | -2.3% | 180,700 |
2020/02/25 | 2,300 | 2,344 | 2,285 | 2,305 | -103 | -4.3% | 204,100 |
2020/02/21 | 2,385 | 2,433 | 2,370 | 2,408 | +20 | +0.8% | 224,400 |
2020/02/20 | 2,421 | 2,421 | 2,381 | 2,388 | -12 | -0.5% | 103,100 |
2020/02/19 | 2,392 | 2,430 | 2,392 | 2,400 | +20 | +0.8% | 139,000 |
2020/02/18 | 2,410 | 2,424 | 2,365 | 2,380 | -34 | -1.4% | 107,900 |
2020/02/17 | 2,437 | 2,437 | 2,396 | 2,414 | -31 | -1.3% | 125,400 |
2020/02/14 | 2,468 | 2,468 | 2,411 | 2,445 | -5 | -0.2% | 191,800 |
2020/02/13 | 2,480 | 2,533 | 2,408 | 2,450 | -127 | -4.9% | 293,200 |
2020/02/12 | 2,587 | 2,590 | 2,560 | 2,577 | +27 | +1.1% | 154,700 |
2020/02/10 | 2,562 | 2,568 | 2,536 | 2,550 | -20 | -0.8% | 74,500 |
2020/02/07 | 2,612 | 2,612 | 2,558 | 2,570 | -16 | -0.6% | 43,200 |
2020/02/06 | 2,575 | 2,604 | 2,575 | 2,586 | +38 | +1.5% | 66,600 |
2020/02/05 | 2,552 | 2,575 | 2,538 | 2,548 | +11 | +0.4% | 109,700 |
2020/02/04 | 2,491 | 2,540 | 2,479 | 2,537 | +40 | +1.6% | 90,300 |
2020/02/03 | 2,481 | 2,515 | 2,475 | 2,497 | -20 | -0.8% | 69,300 |
2020/01/31 | 2,545 | 2,574 | 2,517 | 2,517 | -36 | -1.4% | 125,600 |
2020/01/30 | 2,544 | 2,575 | 2,535 | 2,553 | -36 | -1.4% | 145,200 |
2020/01/29 | 2,599 | 2,599 | 2,567 | 2,589 | -1 | ±0% | 119,700 |
2020/01/28 | 2,589 | 2,615 | 2,573 | 2,590 | -2 | -0.1% | 109,000 |
2020/01/27 | 2,582 | 2,613 | 2,557 | 2,592 | -40 | -1.5% | 146,700 |
2020/01/24 | 2,687 | 2,687 | 2,614 | 2,632 | -136 | -4.9% | 269,600 |
2020/01/23 | 2,766 | 2,776 | 2,748 | 2,768 | -32 | -1.1% | 46,700 |
2020/01/22 | 2,750 | 2,800 | 2,741 | 2,800 | +47 | +1.7% | 86,900 |
2020/01/21 | 2,771 | 2,782 | 2,750 | 2,753 | -27 | -1% | 43,900 |
2020/01/20 | 2,778 | 2,785 | 2,760 | 2,780 | +2 | +0.1% | 48,800 |
2020/01/17 | 2,785 | 2,792 | 2,751 | 2,778 | +5 | +0.2% | 79,800 |
2020/01/16 | 2,797 | 2,798 | 2,761 | 2,773 | -24 | -0.9% | 50,300 |
2020/01/15 | 2,840 | 2,840 | 2,776 | 2,797 | -13 | -0.5% | 75,000 |
2020/01/14 | 2,840 | 2,843 | 2,790 | 2,810 | -30 | -1.1% | 73,000 |
2020/01/10 | 2,835 | 2,857 | 2,829 | 2,840 | +10 | +0.4% | 29,800 |
2020/01/09 | 2,821 | 2,855 | 2,812 | 2,830 | +9 | +0.3% | 67,700 |
2020/01/08 | 2,840 | 2,868 | 2,791 | 2,821 | -51 | -1.8% | 104,500 |
2020/01/07 | 2,836 | 2,877 | 2,836 | 2,872 | +53 | +1.9% | 69,700 |
2020/01/06 | 2,809 | 2,828 | 2,805 | 2,819 | -27 | -0.9% | 95,600 |
2019/12/30 | 2,859 | 2,870 | 2,842 | 2,846 | -41 | -1.4% | 49,800 |
2019/12/27 | 2,912 | 2,930 | 2,883 | 2,887 | -59 | -2% | 115,700 |
2019/12/26 | 2,942 | 2,967 | 2,928 | 2,946 | +9 | +0.3% | 50,700 |
1151~
1200
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム